BIOA (BIOA)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$102.61M
EV / Sales9.95
EV / EBITDA-1.15
EV / Operating Cash Flow-1.16
EV / Free Cash Flow-1.16

Return Metrics (TTM)

Return on Equity (ROE)-29.40%
Return on Assets (ROA)-22.62%
Return on Invested Capital (ROIC)-26.51%
Return on Capital Employed (ROCE)-26.64%

Yield Metrics

Earnings Yield-23.42%
Free Cash Flow Yield-26.04%

Balance Sheet Strength

Net Debt / EBITDA2.66
Current Ratio24.76
Working Capital$376.03M
Tangible Asset Value$379.12M
Net Current Asset Value$373.33M

Working Capital Efficiency

Days Sales Outstanding25.09
Days Payables Outstanding17763.33
Operating Cycle (Days)25.09
Cash Conversion Cycle-17738.25

Capital Allocation

CapEx / Revenue3.09%
CapEx / Operating Cash Flow-0.36%
R&D / Revenue807.16%
SG&A / Revenue278.16%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin100.00%
Operating Margin-1031.46%
Net Profit Margin-896.11%

Solvency

Debt / Equity0.02
Quick Ratio14.24
Cash Ratio9.38

Per Share

Revenue / Share$0.25
FCF / Share-$2.29
PE Ratio-5.91